V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009981 | 330004128 | 1.59 | 54.3 | Curative (C) | 2014-02-05 | 2014-02-23 | Cetuximab 7 day (>Cycle 2) | null | null | 330009018 | CETUXIMAB |
| 330009982 | 330004128 | 1.63 | null | Curative (C) | 2015-12-23 | 2015-12-30 | Carboplatin AUC 6 - 10 | null | null | 330009018 | CARBOPLATIN |
| 330009983 | 330004129 | null | null | Curative (C) | 2014-10-08 | 2014-11-11 | MAP | N | N | 330009031 | MAP |
| 330009984 | 330012403 | 1.8 | null | Palliative (P) | 2017-07-25 | 2017-07-26 | Carboplatin AUC 6 - 10 | null | null | 330009032 | CARBOPLATIN |
| 330009985 | 330013030 | null | 60.3 | Palliative (P) | 2016-04-24 | 2016-05-21 | Etoposide + Ifosfamide (5 days) | N | N | 330009044 | ETOPOSIDE + IFOSFAMIDE |
| 330009989 | 330004145 | 0 | 150.4 | Palliative (P) | null | 2015-03-06 | OST Euramos 1 Closed Trial - M | null | null | 330009102 | METHOTREXATE HIGH DOSE |
| 330009990 | 330004146 | 1.83 | 75 | Palliative (P) | 2016-03-14 | 2016-03-14 | Carboplatin AUC 6 - 10 | N | N | 330009102 | CARBOPLATIN |
| 330009991 | 330004148 | 1.76 | 91.3 | Adjuvant (A) | 2017-06-16 | 2017-06-16 | PAM x 2 pre-surgery (cycles 1&2) | N | N | 330009115 | MAP |
| 330009992 | 330004151 | 1.8 | 95.9 | Palliative (P) | 2016-04-16 | 2016-04-21 | Docetaxel + Gemcitabine with GCSF | 02 | N | 330009138 | DOCETAXEL + GEMCITABINE |
| 330009993 | 330004152 | 1.73 | 67.5 | Palliative (P) | 2013-05-24 | 2013-05-24 | Carboplatin AUC 2 - 5 | 02 | N | 330009140 | CARBOPLATIN |
| 330009994 | 330004152 | 1.73 | 103 | Palliative (P) | 2017-12-22 | 2018-01-11 | OST Euramos 1 Closed Trial - M | 02 | N | 330009140 | METHOTREXATE HIGH DOSE |
| 330009995 | 330004155 | 1.8 | 92 | Curative (C) | null | 2017-02-21 | Rituximab | N | N | 330009166 | RITUXIMAB |
| 330009996 | 330004157 | 0 | null | null | 2015-08-24 | 2015-08-24 | CETUXIMAB | N | N | 330009169 | CETUXIMAB |
| 330009997 | 330004159 | 1.58 | 44.3 | Disease modification (D) | 2017-04-17 | 2017-05-29 | Rituximab | N | N | 330009184 | RITUXIMAB |
| 330009998 | 330004165 | 1.78 | null | Curative (C) | 2013-04-25 | 2013-05-10 | OST Euramos 1 Closed Trial - M | N | N | 330009223 | METHOTREXATE HIGH DOSE |
| 330009999 | 330004169 | null | null | Curative (C) | 2013-04-01 | 2013-05-03 | Etoposide + Ifosfamide (5 days) | N | N | 330009250 | ETOPOSIDE + IFOSFAMIDE |
| 330010000 | 330004175 | null | 82 | Curative (C) | 2015-02-11 | 2016-05-08 | Cetuximab 14 day | N | N | 330009255 | CETUXIMAB |
| 330010001 | 330004175 | null | 55.4 | Curative (C) | null | 2015-09-09 | Carboplatin AUC 2 - 5 | N | Y | 330009255 | CARBOPLATIN |
| 330010002 | 330004177 | 1.91 | 136.5 | Palliative (P) | 2014-06-11 | 2014-06-24 | Rituximab | N | N | 330009271 | RITUXIMAB |
| 330010004 | 330004182 | 1.52 | 60 | Neo-adjuvant (N) | 2014-11-23 | 2014-11-23 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 330009285 | CISPLATIN + FLUOROURACIL |
| 330010007 | 330004187 | null | 68.4 | Palliative (P) | 2018-06-10 | 2018-07-06 | DOCETAXEL + GEMCITABINE | N | N | 330009299 | DOCETAXEL + GEMCITABINE |
| 330010008 | 330004190 | 1.65 | null | Palliative (P) | 2013-12-23 | 2013-12-23 | CARBOPLATIN | 2 | N | 330009311 | CARBOPLATIN |
| 330010009 | 330004192 | 1.79 | 69.2 | Palliative (P) | 2016-06-08 | 2016-07-16 | Carboplatin AUC 6 - 10 | N | N | 330009342 | CARBOPLATIN |
| 330010010 | 330004193 | 1.75 | 89.5 | Curative (C) | null | 2015-10-16 | Carboplatin AUC 2 - 5 | N | N | 330009369 | CARBOPLATIN |
| 330010011 | 330011721 | 1.75 | 48.6 | null | 2016-08-07 | 2016-09-30 | Rituximab | 02 | N | 330009388 | RITUXIMAB |
| 330010012 | 330008294 | 1.71 | 70.7 | Palliative (P) | 2014-01-27 | 2014-03-12 | Docetaxel + Gemcitabine with GCSF | N | N | 330009403 | DOCETAXEL + GEMCITABINE |
| 330010013 | 330004195 | null | 91.3 | Curative (C) | 2018-09-22 | 2018-09-30 | Docetaxel+Gemcitabine (no prior RT) | N | N | 330009422 | DOCETAXEL + GEMCITABINE |
| 330010014 | 330004196 | null | 66 | Neo-adjuvant (N) | 2015-12-28 | 2015-12-28 | MAP | null | null | 330009437 | MAP |
| 330010015 | 330008297 | 1.63 | 57 | Curative (C) | 2015-04-30 | 2015-06-22 | Cetuximab 7 day (>Cycle 2) | N | N | 330009445 | CETUXIMAB |
| 330010016 | 330004200 | 1.68 | 59 | Curative (C) | 2017-08-05 | 2017-10-13 | OST Euramos 1 Closed Trial - AP | N | N | 330009446 | MAP |
| 330010017 | 330004202 | null | 89.1 | Curative (C) | 2016-10-10 | 2016-11-16 | Cetuximab 7 day (>Cycle 2) | 2 | N | 330009450 | CETUXIMAB |
| 330010018 | 330004204 | 1.63 | 0 | Curative (C) | 2015-07-24 | 2015-09-01 | CISPLATIN + FLUOROURACIL | N | Y | 330009693 | CISPLATIN + FLUOROURACIL |
| 330010019 | 330004205 | 1.69 | null | Palliative (P) | 2018-03-27 | 2018-04-14 | Rituximab | N | Y | 330009744 | RITUXIMAB |
| 330010020 | 330004211 | 1.7 | 74.65 | Curative (C) | 2017-05-07 | 2017-05-20 | CISPLATIN + FLUOROURACIL | 2 | N | 330009753 | CISPLATIN + FLUOROURACIL |
| 330010021 | 330004215 | 1.78 | null | Curative (C) | 2015-07-16 | 2015-07-24 | OST Euramos 1 Closed Trial - M | 02 | N | 330009847 | METHOTREXATE HIGH DOSE |
| 330010022 | 330008305 | 1.66 | 52.65 | Adjuvant (A) | 2016-05-02 | 2016-10-07 | ETOPOSIDE + IFOSFAMIDE | N | N | 330009871 | ETOPOSIDE + IFOSFAMIDE |
| 330010023 | 330008307 | 1.57 | 70.6 | Neo-adjuvant (N) | 2016-06-29 | 2016-08-03 | OST Euramos 1 Closed Trial - M | Y | Y | 330010223 | METHOTREXATE HIGH DOSE |
| 330010024 | 330004223 | 1.64 | 82.7 | Palliative (P) | 2016-08-06 | 2016-08-07 | OST Euramos 1 Closed Trial - M | 02 | N | 330010452 | METHOTREXATE HIGH DOSE |
| 330010025 | 330004224 | null | 88 | Curative (C) | 2013-11-22 | 2013-11-25 | PAM x 2 post-surgery (cycles 3&4) | 02 | Y | 330010467 | MAP |
| 330010026 | 330008310 | 1.67 | 89.1 | Palliative (P) | 2016-06-06 | 2016-06-06 | CETUXIMAB | N | N | 330010479 | CETUXIMAB |
| 330010027 | 330004227 | null | 67.5 | Curative (C) | 2018-04-15 | 2018-05-14 | Methotrexate High Dose (3g/m2) | 2 | N | 330010484 | METHOTREXATE HIGH DOSE |
| 330010028 | 330004229 | 1.69 | 44.9 | Curative (C) | 2012-12-06 | 2013-04-23 | Rituximab | N | N | 330010563 | RITUXIMAB |
| 330010031 | 330004236 | 1.85 | 84.9 | Palliative (P) | 2014-05-26 | 2014-07-22 | Carboplatin AUC 6 - 10 | N | N | 330010610 | CARBOPLATIN |
| 330010032 | 330004239 | null | 73 | Curative (C) | 2015-04-25 | 2015-05-18 | Rituximab | 02 | null | 330010656 | RITUXIMAB |
| 330010033 | 330004240 | 1.59 | 62.2 | Palliative (P) | 2014-11-01 | 2014-11-05 | Rituximab (Maintenance) | N | N | 330010659 | RITUXIMAB |
| 330010034 | 330004241 | 1.63 | null | Curative (C) | 2014-10-31 | 2014-12-02 | Carboplatin AUC 2 - 5 | N | Y | 330010664 | CARBOPLATIN |
| 330010035 | 330008322 | 1.81 | 75 | Palliative (P) | 2015-05-06 | 2015-05-14 | CARBOPLATIN | 02 | N | 330010672 | CARBOPLATIN |
| 330010036 | 330004244 | 1.78 | null | Curative (C) | null | 2017-06-03 | Methotrexate High Dose (3g/m2) | 02 | N | 330010681 | METHOTREXATE HIGH DOSE |
| 330010037 | 330004244 | 1.76 | 63.9 | Neo-adjuvant (N) | 2017-06-16 | 2017-10-09 | PAM x 2 post-surgery (cycles 3&4) | null | null | 330010681 | MAP |
| 330010038 | 330004246 | 1.55 | 36.1 | Neo-adjuvant (N) | 2014-07-02 | 2014-07-02 | CETUXIMAB | N | N | 330010701 | CETUXIMAB |